Jiangsu Hengrui Medicine
600276.SS
#484
Rank
โ‚ฌ40.59 B
Marketcap
6,36ย โ‚ฌ
Share price
-3.83%
Change (1 day)
5.32%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ6.58 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are โ‚ฌ6.58 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31โ‚ฌ5.72 B5.22%
2021-12-31โ‚ฌ5.44 B25.69%
2020-12-31โ‚ฌ4.32 B22.94%
2019-12-31โ‚ฌ3.52 B23.06%
2018-12-31โ‚ฌ2.86 B23.82%
2017-12-31โ‚ฌ2.31 B17.79%
2016-12-31โ‚ฌ1.96 B20.94%
2015-12-31โ‚ฌ1.62 B34.45%
2014-12-31โ‚ฌ1.20 B39.67%
2013-12-31โ‚ฌ0.86 B20.91%
2012-12-31โ‚ฌ0.71 B21.04%
2011-12-31โ‚ฌ0.59 B33.27%
2010-12-31โ‚ฌ0.44 B44.54%
2009-12-31โ‚ฌ0.30 B29.48%
2008-12-31โ‚ฌ0.23 B22.49%
2007-12-31โ‚ฌ0.19 B35.53%
2006-12-31โ‚ฌ0.14 B6.02%
2005-12-31โ‚ฌ0.13 B20.11%
2004-12-31โ‚ฌ0.11 B-19.68%
2003-12-31โ‚ฌ0.13 B0.12%
2002-12-31โ‚ฌ0.13 B-9.06%
2001-12-31โ‚ฌ0.15 B